Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2024

Open Access 01-12-2024 | Insulins | Research

Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults

Authors: Ghazaal Alavi Tabatabaei, Noushin Mohammadifard, Hamed Rafiee, Fatemeh Nouri, Asieh Maghami mehr, Jamshid Najafian, Masoumeh Sadeghi, Maryam Boshtam, Hamidreza Roohafza, Fahimeh Haghighatdoost, Marzieh Taheri, Nizal Sarrafzadegan

Published in: Cardiovascular Diabetology | Issue 1/2024

Login to get access

Abstract

Background

The triglyceride glucose (TyG) index is a new and low-cost marker to determine insulin resistant which may be a predictor of cardiovascular disease (CVD). Although available evidence showed that its association with CVD mortality (CVM) and all-cause mortality (ACM) may differ in different populations, scarce data are available in this regard specially in low and middle-income countries.

Purpose

To examine the association between TyG index and risk of CVM and ACM in Iranians.

Methods

This prospective cohort study included 5432 adults (age ≥ 35 years) with no history of CVD events. Fasting glucose and triglyceride were measured at baseline in all participants and TyG index was calculated. Cox frailty model was used to calculate hazard ratios (HRs) for CVM and ACM across the tertiles of TyG index.

Results

After a median follow-up of 11.25 years, a total number of 191 cardiovascular deaths, and 487 all-cause mortality was recorded. The risk of both CVM and ACM increased across the tertiles of TyG index. In the adjusted model for lifestyle and metabolic variables, the risks of ACM and CVM increased by 41% (95% CI 1.11, 1.81; P for trend = 0.005) and 64% (95% CI 1.07, 2.50; P for trend = 0.024), respectively. However, adjustment for diabetes mellitus disappeared the significance for both ACM and CVM. These associations may vary by sex. TyG was not related to the risk of non-CVD mortality.

Conclusion

The predicting value of TyG index for ACM and CVM might be mediated by diabetes status. Further studies are required to confirm these findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies. JAMA Netw Open. 2018;1(7):e183788.PubMedPubMedCentralCrossRef Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies. JAMA Netw Open. 2018;1(7):e183788.PubMedPubMedCentralCrossRef
2.
go back to reference Salari N, Doulatyari PK, Daneshkhah A, Vaisi-Raygani A, Jalali R, Jamshidi PK, et al. The prevalence of metabolic syndrome in cardiovascular patients in Iran: a systematic review and meta-analysis. Diabetol Metab Syndr. 2020;12(1):96.PubMedPubMedCentralCrossRef Salari N, Doulatyari PK, Daneshkhah A, Vaisi-Raygani A, Jalali R, Jamshidi PK, et al. The prevalence of metabolic syndrome in cardiovascular patients in Iran: a systematic review and meta-analysis. Diabetol Metab Syndr. 2020;12(1):96.PubMedPubMedCentralCrossRef
3.
go back to reference Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128.PubMedPubMedCentralCrossRef Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128.PubMedPubMedCentralCrossRef
4.
go back to reference Mohammad NS, Nazli R, Zafar H, Fatima S. Effects of lipid based multiple micronutrients supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial. Pak J Med Sci. 2022;38(1):219–26.PubMedPubMedCentral Mohammad NS, Nazli R, Zafar H, Fatima S. Effects of lipid based multiple micronutrients supplement on the birth outcome of underweight pre-eclamptic women: a randomized clinical trial. Pak J Med Sci. 2022;38(1):219–26.PubMedPubMedCentral
6.
go back to reference Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.PubMedPubMedCentralCrossRef Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.PubMedPubMedCentralCrossRef
7.
go back to reference Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):1–11.CrossRef Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):1–11.CrossRef
8.
go back to reference Xiong S, Chen Q, Long Y, Su H, Luo Y, Liu H, et al. Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome. Cardiovasc Diabetol. 2023;22(1):56.PubMedPubMedCentralCrossRef Xiong S, Chen Q, Long Y, Su H, Luo Y, Liu H, et al. Association of the triglyceride-glucose index with coronary artery disease complexity in patients with acute coronary syndrome. Cardiovasc Diabetol. 2023;22(1):56.PubMedPubMedCentralCrossRef
9.
go back to reference Caliskan S, Boyuk F. Is triglyceride-glucose index a valuable parameter in peripheral artery disease? Cureus. 2023;15(2):e35532.PubMedPubMedCentral Caliskan S, Boyuk F. Is triglyceride-glucose index a valuable parameter in peripheral artery disease? Cureus. 2023;15(2):e35532.PubMedPubMedCentral
10.
go back to reference Liao C, Xu H, Jin T, Xu K, Xu Z, Zhu L, et al. Triglyceride-glucose index and the incidence of stroke: a meta-analysis of cohort studies. Front Neurol. 2022;13:1033385.PubMedCrossRef Liao C, Xu H, Jin T, Xu K, Xu Z, Zhu L, et al. Triglyceride-glucose index and the incidence of stroke: a meta-analysis of cohort studies. Front Neurol. 2022;13:1033385.PubMedCrossRef
11.
go back to reference Zhou D, Liu X-C, Kenneth L, Huang Y-Q, Feng Y-Q. A non-linear association of triglyceride glycemic index with cardiovascular and all-cause mortality among patients with hypertension. Front Cardiovasc Med. 2022;8:2222.CrossRef Zhou D, Liu X-C, Kenneth L, Huang Y-Q, Feng Y-Q. A non-linear association of triglyceride glycemic index with cardiovascular and all-cause mortality among patients with hypertension. Front Cardiovasc Med. 2022;8:2222.CrossRef
12.
go back to reference Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27.PubMedCrossRef Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27.PubMedCrossRef
13.
go back to reference Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of overweight or obesity and abdominal obesity in Iranian population: a population-based study of Northwestern Iran. Iran J Public Health. 2018;47(10):1583–92.PubMedPubMedCentral Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of overweight or obesity and abdominal obesity in Iranian population: a population-based study of Northwestern Iran. Iran J Public Health. 2018;47(10):1583–92.PubMedPubMedCentral
14.
go back to reference Mazloomzadeh S, Rashidi Khazaghi Z, Mousavinasab N. The prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis. Iran J Public Health. 2018;47(4):473–80.PubMedPubMedCentral Mazloomzadeh S, Rashidi Khazaghi Z, Mousavinasab N. The prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis. Iran J Public Health. 2018;47(4):473–80.PubMedPubMedCentral
15.
go back to reference Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadi-Lari M. Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys. BMC Public Health. 2022;22(1):1216.PubMedPubMedCentralCrossRef Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadi-Lari M. Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys. BMC Public Health. 2022;22(1):1216.PubMedPubMedCentralCrossRef
16.
go back to reference Coll JL, del Bibiloni MM, Salas R, Pons A, Tur JA. Prevalence and related risk factors of overweight and obesity among the adult population in the Balearic Islands, a Mediterranean Region. Obesity facts. 2015;8(3):220–33.PubMedPubMedCentralCrossRef Coll JL, del Bibiloni MM, Salas R, Pons A, Tur JA. Prevalence and related risk factors of overweight and obesity among the adult population in the Balearic Islands, a Mediterranean Region. Obesity facts. 2015;8(3):220–33.PubMedPubMedCentralCrossRef
17.
go back to reference Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13:1–10.CrossRef Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13:1–10.CrossRef
18.
go back to reference Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–10.PubMed Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–10.PubMed
19.
go back to reference Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum Á, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23–33.PubMedCrossRef Lopez-Jaramillo P, Gomez-Arbelaez D, Martinez-Bello D, Abat MEM, Alhabib KF, Avezum Á, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2023;4(1):e23–33.PubMedCrossRef
20.
go back to reference Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, et al. The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens. 2011;25(9):545–53.PubMedCrossRef Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N, et al. The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens. 2011;25(9):545–53.PubMedCrossRef
21.
go back to reference Iida S, Osawa S, Yonemitsu H. A new precipitation method with magnetic separation for high-density-lipoprotein cholesterol assay. Clin Chim Acta. 1994;228(2):133–42.PubMedCrossRef Iida S, Osawa S, Yonemitsu H. A new precipitation method with magnetic separation for high-density-lipoprotein cholesterol assay. Clin Chim Acta. 1994;228(2):133–42.PubMedCrossRef
22.
go back to reference American Diabetes Association. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022; 40(1): 10–38. American Diabetes Association. Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers. Clin Diabetes. 2022; 40(1): 10–38.
23.
go back to reference Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.PubMedCrossRef Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.PubMedCrossRef
24.
go back to reference Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37.PubMedCrossRef Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37.PubMedCrossRef
25.
go back to reference Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.PubMedCrossRef Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.PubMedCrossRef
26.
go back to reference Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):1–8.CrossRef Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):1–8.CrossRef
27.
go back to reference Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care. 2019;42(8):1569–73.PubMedCrossRef
28.
go back to reference Pranata R, Huang I, Lim MA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus—a systematic review and dose–response meta-analysis of cohort studies. Endocrine. 2021;74(2):254–62.PubMedCrossRef Pranata R, Huang I, Lim MA, Vania R. The association between triglyceride-glucose index and the incidence of type 2 diabetes mellitus—a systematic review and dose–response meta-analysis of cohort studies. Endocrine. 2021;74(2):254–62.PubMedCrossRef
29.
go back to reference Shen J, Feng B, Fan L, Jiao Y, Li Y, Liu H, et al. Triglyceride glucose index predicts all-cause mortality in oldest-old patients with acute coronary syndrome and diabetes mellitus. BMC Geriatr. 2023;23(1):78.PubMedPubMedCentralCrossRef Shen J, Feng B, Fan L, Jiao Y, Li Y, Liu H, et al. Triglyceride glucose index predicts all-cause mortality in oldest-old patients with acute coronary syndrome and diabetes mellitus. BMC Geriatr. 2023;23(1):78.PubMedPubMedCentralCrossRef
30.
go back to reference Liu X-C, He G-D, Lo K, Huang Y-Q, Feng Y-Q. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2021;7:628109.PubMedPubMedCentralCrossRef Liu X-C, He G-D, Lo K, Huang Y-Q, Feng Y-Q. The triglyceride-glucose index, an insulin resistance marker, was non-linear associated with all-cause and cardiovascular mortality in the general population. Front Cardiovasc Med. 2021;7:628109.PubMedPubMedCentralCrossRef
31.
go back to reference Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):1–13.CrossRef Zhang Y, Ding X, Hua B, Liu Q, Gao H, Chen H, et al. Predictive effect of triglyceride-glucose index on clinical events in patients with type 2 diabetes mellitus and acute myocardial infarction: results from an observational cohort study in China. Cardiovasc Diabetol. 2021;20(1):1–13.CrossRef
32.
go back to reference Sun M, Guo H, Wang Y, Ma D. Association of triglyceride glucose index with all-cause and cause-specific mortality among middle age and elderly US population. BMC Geriatr. 2022;22(1):461.PubMedPubMedCentralCrossRef Sun M, Guo H, Wang Y, Ma D. Association of triglyceride glucose index with all-cause and cause-specific mortality among middle age and elderly US population. BMC Geriatr. 2022;22(1):461.PubMedPubMedCentralCrossRef
33.
go back to reference Lopez-Jaramillo P, Lahera V, Lopez-Lopez J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther Adv Cardiovasc Dis. 2011;5(2):119–31.PubMedCrossRef Lopez-Jaramillo P, Lahera V, Lopez-Lopez J. Epidemic of cardiometabolic diseases: a Latin American point of view. Ther Adv Cardiovasc Dis. 2011;5(2):119–31.PubMedCrossRef
34.
go back to reference Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):e748–60.PubMedCrossRef Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):e748–60.PubMedCrossRef
35.
go back to reference Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.PubMedPubMedCentralCrossRef Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.PubMedPubMedCentralCrossRef
36.
go back to reference Yu Y, Wang J, Ding L, Huang H, Cheng S, Deng Y, et al. Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Diabetol Metab Syndr. 2023;15(1):136.PubMedPubMedCentralCrossRef Yu Y, Wang J, Ding L, Huang H, Cheng S, Deng Y, et al. Sex differences in the nonlinear association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Diabetol Metab Syndr. 2023;15(1):136.PubMedPubMedCentralCrossRef
38.
go back to reference Lu YW, Chang CC, Chou RH, Tsai YL, Liu LK, Chen LK, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021;20(1):206.PubMedPubMedCentralCrossRef Lu YW, Chang CC, Chou RH, Tsai YL, Liu LK, Chen LK, et al. Gender difference in the association between TyG index and subclinical atherosclerosis: results from the I-Lan Longitudinal Aging Study. Cardiovasc Diabetol. 2021;20(1):206.PubMedPubMedCentralCrossRef
39.
go back to reference Yang K, Liu W. Triglyceride and glucose index and sex differences in relation to major adverse cardiovascular events in hypertensive patients without diabetes. Front Endocrinol (Lausanne). 2021;12:761397.PubMedCrossRef Yang K, Liu W. Triglyceride and glucose index and sex differences in relation to major adverse cardiovascular events in hypertensive patients without diabetes. Front Endocrinol (Lausanne). 2021;12:761397.PubMedCrossRef
40.
go back to reference Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361.PubMedPubMedCentralCrossRef Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361.PubMedPubMedCentralCrossRef
41.
go back to reference Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.PubMedPubMedCentralCrossRef Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.PubMedPubMedCentralCrossRef
42.
go back to reference GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736–88. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736–88.
43.
go back to reference Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):1–12.CrossRef Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):1–12.CrossRef
44.
go back to reference Gao S, Ma W, Huang S, Lin X, Yu M. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutr Metab Cardiovasc Dis. 2021;31(11):3184–92.PubMedCrossRef Gao S, Ma W, Huang S, Lin X, Yu M. Impact of triglyceride-glucose index on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutr Metab Cardiovasc Dis. 2021;31(11):3184–92.PubMedCrossRef
45.
go back to reference da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671–82.PubMedCrossRef
Metadata
Title
Association of the triglyceride glucose index with all-cause and cardiovascular mortality in a general population of Iranian adults
Authors
Ghazaal Alavi Tabatabaei
Noushin Mohammadifard
Hamed Rafiee
Fatemeh Nouri
Asieh Maghami mehr
Jamshid Najafian
Masoumeh Sadeghi
Maryam Boshtam
Hamidreza Roohafza
Fahimeh Haghighatdoost
Marzieh Taheri
Nizal Sarrafzadegan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2024
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-024-02148-8

Other articles of this Issue 1/2024

Cardiovascular Diabetology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine